Advanced-Stage (FIGO III–IV) Epithelial Ovarian Cancer: Multivariate Analysis of Prognostic Factors in an Area without a Tertiary Referral Oncology Center. A Population-Based Study

Publisher： Karger

E-ISSN： 2296-5262|22|5|406-410

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.5, 1999-11, pp. : 406-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stage IV breast cancer: a population‐based study about prognostic factors according to HER2 and HR status

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 6, 2015-11 ,pp. : 920-928

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose Escalation of Carboplatin and Cyclophosphamide Supported by GM-CSF in the Treatment of Patients with Advanced Ovarian Cancer (FIGO III and IV) – a Phase I Study

By  

Oncology Research and Treatment, Vol. 22, Iss. 6, 2000-01 ,pp. : 502-506

Karger

Access to resources Recommend Favorite

Cell proliferation, measured as flow cytometric S‐phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population‐based study

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 10, 2015-10 ,pp. : 1064-1073

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cell proliferation, measured as flow cytometric S‐phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population‐based study

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 1-6349, Iss. 10, 2015-10 ,pp. : 1064-1073

John Wiley & Sons Inc

Access to resources Recommend Favorite

Administration of adjuvant chemotherapy for stage II‐III colon cancer patients: An European population‐based study

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1480-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite